HLA
PTLA

Hamilton Lane Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Hamilton Lane Advisors’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-53,359
Closed -$1.35M – 70
2014
Q3 		$1.35M Buy
53,359
+3,599
+7% +$94.8K 0.44% 33
2014
Q2 		$1.45M Sell
49,760
-240,827
-83% -$5.83M 0.45% 29
2014
Q1 		$7.53M Buy
+290,587
New +$7.75M 3.02% 9

Other funds holding PTLA

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Hamilton Lane Advisors's PTLA Position: Q4 2014 in Review

Hamilton Lane Advisors sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q4 2014, closing a stake of 53,359 shares — an estimated $1.35M sold.

Hamilton Lane Advisors first reported a position in PTLA in Q1 2014 and held it in 3 quarters. The position peaked at $7.53M in Q1 2014. 133 funds tracked by Wall St. Rank hold PTLA as of Q4 2014.

  • Hamilton Lane Advisors reported no remaining Portola Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
  • Hamilton Lane Advisors sold 53,359 Portola Pharmaceuticals, Inc. shares in Q4 2014, an estimated $1.35M.
  • Hamilton Lane Advisors first reported a position in Portola Pharmaceuticals, Inc. in Q1 2014 and held it in 3 quarters.
  • Hamilton Lane Advisors's Portola Pharmaceuticals, Inc. position peaked at $7.53M in Q1 2014.
  • 133 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2014.

Based on Hamilton Lane Advisors's 13F filing for Q4 2014, filed 26 Jan 2015.